medigraphic.com
ISSN 1025-0255 (Electronic)

2013, Number 4

<< Back Next >>

AMC 2013; 17 (4)

American trypanosomiasis in Latin American students

Monteagudo CA, Salazar CCE, Santana TTN, Agüero PM

Language: Spanish
References: 24
Page:
PDF size: 128.51 Kb.


ABSTRACT

Background: Chagas' disease or trypanosomiasis is a tropical parasitic disease, generally chronic, caused by trypanosome cruzy. It presents three stages: severe phase, undetermined phase, and chronic phase. The disease affects the nervous system, the digestive system, and the heart. It produces neurological disorders, damage in the cardiac muscle (cardiomyopathy) and in the digestive tract (megacolon and/or megaesophagous). It was established that some students from the Latin American School of Medicine were affected by the disease, which does not exists in Cuba.
Objective: to get to know the real health situation of the Latin students diagnosed with American trypanosomiasis.
Methods: a descriptive, observational study was conducted at the University of Medical Sciences of Camagüey in students who suffered from Chagas' disease. The universe, which coincided with the sample, was composed of 29 Latin American students.
Results: male sex was predominant. The average age was of 25 years old. Bolivia was the country that was predominant in terms of frequency. Bradycardia was the most frequent sign. Electrocardiogram produced more altered results than normal ones. In 11 of the patients the family pathological precedents were gathered. A high percent of the patients finished their treatment at the Pedro Kourí Institute. One of the patients died.
Conclusions: students with Chagas' disease had an average of six years of been diagnosed but not of been sick. They are not asymptomatic. Electrocardiogram should be greatly valued for its high positive results. Contrast studies of the digestive tract should be made looking for megaesophagous or any other problem. An active analysis of Bolivian students should be kept. Family pathological precedents should be greatly valued. Monitoring consultations should be kept at no more than three-month intervals in order to see the evolution, mainly from the cardiovascular point of view.


REFERENCES

  1. Solórzano Santos F. Enfermedad de Chagas en el siglo XXI. Un panorama histórico. Bol Med Hosp Infant Mex [Internet]. 2008 [citado 10 Jun 2008];65(1):[aprox. 14 p.]. Disponible en: http://search.ebscohost.com/login.aspx?direct=true&db=lth & Create PDF

  2. Velasco Castrejón Ó, Rivas Sánchez B. Apuntes para la historia de la enfermedad de Chagas en México. Bol Med Hosp Infant Mex [Internet]. 2008 [citado 10 Jun 2008];65(1):[aprox. 9 p.].Disponible en: http://search.ebscohost.com/login.aspx?direct=true & db=lth & AN=31503618 & loginpage=login.asp & lang=es & site=ehostlive

  3. Rojas de Arias A. Social and epidemiological determinants of Chagas disease: basic information for a surveillance and control policy in the Southern Cone. Mem Inst Oswaldo Cruz. 2007; 102(Suppl 1):19-21.

  4. Workshop on epidemiology and social determining factors of Chagas disease: basic information for surveillance and control policy in Latin America introduction, regional context, precedings, and recommendations. Mem Inst Oswaldo Cruz. 2007;102(Suppl 1):5-10.

  5. Torpy JM, Burke AE, Glass RM. JAMA patient page. Chagas disease. JAMA. 2007;298(18):222-9.

  6. Villa Contreras L, Morote S, Bernal O, Bulla D, Albajar-Vinas P. Access to diagnosis and treatment of Chagas disease/infection in endemic and non-endemic countries in the XXI century. Mem Inst Oswaldo Cruz. 2007;102(Suppl 1):87-94.

  7. Sánchez Negrette O, Sánchez Valdéz FJ, Lacunza O´Relley CD, García Bustos MF. Serological evaluation of specific-antibody levels in patients treated for chronic Chagas' disease. Clin Vaccine Immunol. [Internet]. 2008 [citado 2 Jun 2008];15(2):[aprox. 9 p.]. Disponible en: http://www.pubmedcentral.nih.gov/articlerender. fcgi?tool =pubmed & pubmedid=18057184

  8. Jannin Bermejo J, Villa Mc´Grey L. An overview of Chagas disease treatment. Mem Inst Oswaldo Cruz. 2007;102(Suppl 1):95-7.

  9. Valerio Nascimento L, Roure LozadaS, Sabria Méndez M. Clinical, electrocardiographic and echocardiographic abnormalities in Latin American migrants with newly diagnosed Chagas disease 2005-2009, Barcelona, Spain. Euro Surveill. 2011 Sep 22;16(38):pii:199-71. PubMed PMID: 21958530. http://preview.ncbi.nlm.nih.gov/pubmed/21958530

  10. Schmunis GA. Epidemiology of Chagas disease in nonendemic countries: the role of international migration. Mem Inst Oswaldo Cruz. 2007;102(Suppl 1):75-85.

  11. Silveira D´silva AC. Epidemiological and social determinants of Chagas disease and its control in the Amazon countries—group discussion. Mem Inst Oswaldo Cruz. 2007;102(Suppl 1):71-4.

  12. Aguilar Hinojosa HM, Abad-Franch Camisola F, Días Arredondo JC, Junqueira Felipe AC, Coura Meléndez JR. Chagas disease in the Amazon region. Mem Inst Oswaldo Cruz. 2007;102(Suppl 1):47-56.

  13. Coura Meléndez JR. Chagas disease: what is known and what is needed—a background article. Mem Inst Oswaldo Cruz. 2007;102(Suppl 1):113-22.

  14. Aranda Fraustro A, Chávez Rentería B, Ballinas Verdugo MA, Arce Fonseca M, Medrano Castro GA, de Micheli Serra A. [Electrohistological comparison in a case of Chagasic chronic cardiomyopathy]. Arch Cardiol Mex. 2007;77(3):249-52.

  15. Borges-Pereira Costa J, Xavier Pérez de Corcho SS, de Sousa Aflexneder AS, de Castro Arjona JA, Zauza Contrer PL, Coura Meléndez JR. Prevalence of left ventricular aneurysms among chronic Chagas disease patients from two areas in the State of PiauÃ, Brazil. Rev Soc Bras Med Trop. 2007;40(5):521-6.

  16. Gurgel Dominico CB, Almeida Cervantes EA. Frequency of hypertension in patients with chronic Chagas disease and its consequences on the heart: a clinical and pathological study. Arq Bras Cardiol [Internet]. 2007 [citado 2 Jun 2008];89(3):[aprox. 14 p.]. Disponible en: http://www.scielo.br/scielo.php?script= sci_arttext & pid=S00 66-782X2007001500008 & lng=en & nrm=iso & tlng=en

  17. Nascimento Barreiro BR, Araújo Alpizar CG, Rocha Moreno MO, Domingues Díaz JD, Rodrigues Bravo AB, Barros Esquivel MV, et al. The prognostic significance of electrocardiographic changes in Chagas disease. J Electrocardiol. 2012 Jan-Feb [citado 2 Jun 2008];45(1):[aprox. 5 p.]. Disponible en: http://preview.ncbi.nlm.nih.gov/pubmed/21704321.

  18. New global effort to eliminate Chagas disease. Wkly Epidemiol Rec [Internet] 2007 [citado 10 Jun 2008];82(28-29):[aprox 4 p.]. Disponible en: http://search.ebscohost.com/login.aspx?direct=true & db=aph & AN=25895442 & loginpage=login.asp & lang=es & site=ehostlive

  19. Abad-Franch Ávalos F, Monteiro Roche FA. Biogeography and evolution of Amazonian triatomines (Heteroptera: Reduviidae): implications for Chagas disease surveillance in humid forest ecoregions. Mem Inst Oswaldo Cruz. 2007;102(Suppl 1):57-70.

  20. Campbell-Lendrum DH, Angulo Vilaplana M, Tarazona Parra GJ, Restrepo Benavides N. Houselevel risk factors for triatomine infestation in Colombia. Int J Epidemiol. 2007;36(4):866-72.

  21. Bern C, Montgomery SP, Herwaldt BL, Rassi A, Marin-Neto JA, Dantas RO, et al. Evaluation and treatment of chagas disease in the United States: a systematic review. JAMA. 2007;298(18):2171-81.

  22. Lescure FX,Canestri A, Melliez H, Jauréguiberry S, Develoux M, Dorent R, et al. Chagas Disease, France. Emerging Infect. Dis [Internet] 2008 [citado 10 Jun 2008];14(4):[aprox 8 p.]. Disponible en: http://search.ebscohost. com/lo gin.aspx?direct=true & db=aph & AN=31536287 & loginpage=login. asp & lang=es & site=ehostlive

  23. Briceño-León R, Méndez Galván J. The social determinants of Chagas disease and the transformations of Latin America. Mem Inst Oswaldo Cruz. 2007;102(Suppl 1):109-12.

  24. Global strategy to prevent transmission of Chagas disease. WHO Drug Inf [Internet]. 2007 [citado 10 Jun 2008];21(3):[aprox 12 p.]. Disponible en: http://search.ebscohost.com/lo gin.aspx?direct=true & db=aph & AN=27746095 & loginpage=login.asp & lang=es & site=ehostlive




2020     |     www.medigraphic.com